As businesses become increasingly global, changes are also taking place at an extraordinary pace. Compliance is critical for large economies, industry regulations, and enterprise operations. BGI ...
On November 29, 2022, BGI Genomics and the University of Pécs (UP) agreed to launch a joint laboratory in Hungary. This is part of the cooperation agreement signed between BGI Group, the parent ...
On November 30, 2021, a jury in the patent infringement suits between Illumina, Inc. and BGI Genomics Co. in the U.S. District Court for the Northern District of California returned a verdict ...
The formal launch of the BGI/Natera Signatera Assay is the next step towards achieving global access to personalized ctDNA testing AUSTIN, Texas and SHENZHEN, China, June 24, 2021 /PRNewswire/ -- ...
At BGI Genomics, we believe it is our responsibility to not only enhance global health outcomes, but also to help make the places we work and live in better. This year, we stepped up our social ...
May 6 (Reuters) - A Delaware jury on Friday ordered Illumina Inc (ILMN.O), opens new tab to pay more than $333 million to a U.S. unit of Chinese genomics company BGI ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global genomics market since 2014 and the market is poised to grow by USD 17.23 billion during 2020-2024, progressing at a CAGR of almost 13% ...
SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--Nebula Genomics, the leading privacy-focused personal genomics company, today announced a new product at an unmatched price: 30x whole-genome sequencing for ...
On November 29, 2022, BGI Genomics and the University of Pécs (UP) agreed to launch a joint laboratory in Hungary. This is part of the cooperation agreement signed between BGI Group, the parent ...
The board of Complete Genomics has recommended that its shareholders accept a $117.6 million takeover bid by China’s BGI-Shengzhen. Under terms of the agreement, a wholly owned U.S. subsidiary of ...
SYDNEY (Reuters) - The Chinese government has made an investment in BGI Genomics Co, a listed Chinese company that has supplied millions of COVID-19 tests globally as the gene firm seeks to fund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results